BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7677445)

  • 1. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.
    van Leeuwen MA; Westra J; Limburg PC; van Riel PL; van Rijswijk MH
    Ann Rheum Dis; 1995 Aug; 54(8):674-7. PubMed ID: 7677445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
    Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
    Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
    Knudsen LS; Klarlund M; Skjødt H; Jensen T; Ostergaard M; Jensen KE; Hansen MS; Hetland ML; Nielsen HJ; Johansen JS
    J Rheumatol; 2008 Jul; 35(7):1277-87. PubMed ID: 18597410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
    Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis.
    Boss B; Neeck G
    Z Rheumatol; 2000; 59 Suppl 2():II/62-4. PubMed ID: 11155806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
    Liou LB
    Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
    van Leeuwen MA; van Rijswijk MH; Sluiter WJ; van Riel PL; Kuper IH; van de Putte LB; Pepys MB; Limburg PC
    J Rheumatol; 1997 Jan; 24(1):20-7. PubMed ID: 9002006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
    Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
    Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
    Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis treated with tenidap and piroxicam. Clinical associations with cytokine modulation by tenidap.
    Littman BH; Drury CE; Zimmerer RO; Stack CB; Law CG
    Arthritis Rheum; 1995 Jan; 38(1):29-37. PubMed ID: 7818568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.
    Markatseli TE; Voulgari PV; Alamanos Y; Drosos AA
    J Rheumatol; 2011 Jan; 38(1):44-52. PubMed ID: 20952476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study.
    Kuuliala A; Eberhardt K; Takala A; Kautiainen H; Repo H; Leirisalo-Repo M
    Ann Rheum Dis; 2002 Mar; 61(3):242-6. PubMed ID: 11830430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.